Tirzepatide vs Ipamorelin

A comprehensive, data-driven comparison of Tirzepatide (Mounjaro) and Ipamorelin (NNC 26-0161). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.

Tirzepatide
FDA Approved
Type 2 diabetes, chronic weight management, and obstructive sleep apnea
Evidence
High
Avg. Weight Loss22.5%
Monthly Cost$1,100 - $1,100/mo
DosingWeekly
ManufacturerEli Lilly
Ipamorelin
Category 2 (pending reclassification)
Growth hormone optimization
Evidence
Emerging
Monthly Cost$35 - $70/mo
DosingDaily

Side-by-Side Comparison

PropertyTirzepatide
Mounjaro, Zepbound
Ipamorelin
NNC 26-0161
FDA Status
FDA Approved
Category 2 (pending reclassification)
Category
Weight Loss
Growth Hormone
Primary Use
Type 2 diabetes, chronic weight management, and obstructive sleep apnea
Growth hormone optimization
Weight Loss %
22.5%
N/A
Monthly Cost
$1,100 - $1,100/mo
$35 - $70/mo
Administration
Subcutaneous injection
Subcutaneous injection
Typical Dose
15mg weekly (max dose)
200-300mcg 2-3x daily
Frequency
Weekly
Daily
Mechanism

Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric emptying, and decreases appetite

Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH release without affecting cortisol or prolactin

Common Side Effects
  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • +3 more
  • Injection site reactions
  • Increased hunger
  • Headache
  • Mild water retention
Serious Side Effects
  • Pancreatitis
  • Hypoglycemia
  • Acute gallbladder disease
  • Hypersensitivity reactions
  • +1 more
  • Potential insulin resistance
  • Unknown long-term effects
Evidence Quality
High
Emerging
Clinical Trial Phase
Approved
N/A

Key Differences

  • 1Tirzepatide is FDA-approved, while Ipamorelin is currently category 2 (pending reclassification).
  • 2Tirzepatide has clinical weight loss data (22.5%), while Ipamorelin is not primarily indicated for weight loss.
  • 3Ipamorelin is generally more affordable ($35 - $70/mo) compared to Tirzepatide ($1,100 - $1,100/mo).
  • 4Tirzepatide is dosed weekly, while Ipamorelin is daily.
  • 5Tirzepatide has high-quality evidence, while Ipamorelin has emerging-quality evidence.
  • 6They belong to different categories: Tirzepatide (Weight Loss) vs Ipamorelin (Growth Hormone).

Which Is Better For...

TI

Tirzepatide

Those seeking an FDA-approved treatment with established safety data

IP

Ipamorelin

More budget-friendly option with lower monthly costs

TI

Tirzepatide

More convenient dosing schedule (weekly)

IP

Ipamorelin

Fewer commonly reported side effects

TI

Tirzepatide

Stronger clinical evidence base to support its use

Get Tirzepatide or Ipamorelin Online

Vetted telehealth providers that prescribe either peptide.

PeptideVS may earn a commission from providers listed below. Our editorial data is independent - see our disclosure for details.

Henry Meds

Sponsored

Featured

Compounded GLP-1 therapy with flat monthly pricing and no insurance hassle.

Starting price
From $297/mo
  • Flat monthly price, no insurance required
  • Compounded semaglutide and tirzepatide
  • Licensed providers in 50 states
See Henry Meds pricing

We may earn a commission when you sign up.

Mochi Health

Sponsored

Featured

Obesity-medicine-trained clinicians and a care team built around women.

Starting price
From $79/mo + medication
  • Obesity-medicine-trained MDs and RDs
  • Compounded and brand-name GLP-1 options
  • Insurance-aware pricing and savings tools
Check Mochi eligibility

We may earn a commission when you sign up.

Found Health

Sponsored

Weight-care program combining GLP-1s with behavior coaching and nutritionists.

Starting price
From $99/mo + medication
  • Whole-person program, not just a prescription
  • Insurance-first with cash-pay fallback
  • Nutrition and habit coaching included
Explore Found Health

We may earn a commission when you sign up.

Ro Body

Sponsored

Brand-name Wegovy and Zepbound plus compounded options, handled end to end.

Starting price
From $145/mo
  • Brand-name and compounded GLP-1 paths
  • Insurance navigation built into intake
  • Nationwide telehealth with ongoing check-ins
Start with Ro Body

We may earn a commission when you sign up.

Hers Weight

Sponsored

GLP-1 injections paired with behavior coaching for long-term weight care.

Starting price
From $165/mo
  • Compounded GLP-1 with licensed providers
  • Coaching and habit support in-app
  • Transparent monthly pricing
See Hers Weight plans

We may earn a commission when you sign up.

PlushCare

Sponsored

Primary-care telehealth with broad Rx coverage and same-day appointments.

Starting price
From $16.99/mo membership
  • Broad primary-care scope, not GLP-1-only
  • Same-day video visits in all 50 states
  • Works with insurance for most plans
Book a PlushCare visit

We may earn a commission when you sign up.

Eden

Sponsored

Research peptide telehealth covering recovery, longevity, and growth-hormone protocols.

Starting price
From $120/mo
  • Non-GLP-1 peptide catalog (GHRH, healing, longevity)
  • Licensed prescriber intake, US pharmacy fulfillment
  • Multi-peptide stacks available
Browse Eden protocols

We may earn a commission when you sign up.

Cost Comparison

PeptideMonthly Cost RangeFDA StatusManufacturer
Tirzepatide$1,100 - $1,100/mo
FDA Approved
Eli Lilly
Ipamorelin$35 - $70/mo
Category 2 (pending reclassification)
Various research labs

Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.

Frequently Asked Questions

What is the main difference between Tirzepatide and Ipamorelin?

Tirzepatide works via Dual GIP/GLP-1 receptor agonist that enhances insulin secretion, reduces glucagon, slows gastric. Ipamorelin works via Selective growth hormone secretagogue that binds to ghrelin receptors to stimulate GH. They differ in FDA approval status, efficacy data, and cost.

Which is more effective for weight loss, Tirzepatide or Ipamorelin?

Tirzepatide has demonstrated 22.5% average weight loss in clinical trials. Ipamorelin is not primarily used for weight loss.

How much does Tirzepatide cost compared to Ipamorelin?

Tirzepatide typically costs $1,100 - $1,100/mo, while Ipamorelin costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.

Are Tirzepatide and Ipamorelin FDA approved?

Tirzepatide is FDA-approved. Ipamorelin is not FDA-approved (Category 2 (pending reclassification)). FDA approval indicates the treatment has met rigorous safety and efficacy standards.

What are the side effects of Tirzepatide vs Ipamorelin?

Common side effects of Tirzepatide include Nausea, Diarrhea, Decreased appetite. Common side effects of Ipamorelin include Injection site reactions, Increased hunger, Headache. Always consult a healthcare provider about potential side effects.

Can I switch from Tirzepatide to Ipamorelin?

Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.

Learn More

Tirzepatide Full Profile
Type 2 diabetes, chronic weight management, and obstructive sleep apnea

Tirzepatide is a dual-action peptide approved by the FDA as Mounjaro for type 2 diabetes and Zepbound for weight management. In December 2024, Zepbound became the first and only medication approved fo...

View Full Tirzepatide Guide
Ipamorelin Full Profile
Growth hormone optimization

Ipamorelin is a pentapeptide that selectively stimulates growth hormone release by mimicking ghrelin, the hunger hormone. Unlike many other GH secretagogues, ipamorelin does not significantly increase...

View Full Ipamorelin Guide

Other Popular Comparisons

Medical Disclaimer

The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Tirzepatide and Ipamorelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.